These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34093945)

  • 21. GATA6-AS1 inhibits ovarian cancer cell proliferation and migratory and invasive abilities by sponging miR-19a-5p and upregulating TET2.
    Xu H; Wang X; Zhang Y; Zheng W; Zhang H
    Oncol Lett; 2021 Oct; 22(4):718. PubMed ID: 34429758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. lncRNA RHPN1-AS1 Promotes Ovarian Cancer Growth and Invasiveness Through Inhibiting miR-1299.
    Zhao L; Liu T; Zhang X; Zuo D; Liu C
    Onco Targets Ther; 2020; 13():5337-5344. PubMed ID: 32606751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p.
    Chao H; Zhang M; Hou H; Zhang Z; Li N
    Life Sci; 2020 Feb; 243():117296. PubMed ID: 31935390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p.
    Huang X; Shi H; Shi X; Jiang X
    J Biol Res (Thessalon); 2021 Aug; 28(1):20. PubMed ID: 34399848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA FAS-AS1 inhibits the progression of non-small cell lung cancer through regulating miR-19a-5p.
    Yang CB; Xiao SW; Cheng SM; Zhang C
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3775-3785. PubMed ID: 32329854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
    Suo ST; Gong P; Peng XJ; Niu D; Guo YT
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
    Dong S; Wang R; Wang H; Ding Q; Zhou X; Wang J; Zhang K; Long Y; Lu S; Hong T; Ren H; Wong K; Sheng X; Wang Y; Zeng Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):110. PubMed ID: 30823895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
    Huang N; Guo W; Ren K; Li W; Jiang Y; Sun J; Dai W; Zhao W
    Front Oncol; 2019; 9():1103. PubMed ID: 31696057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
    Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. lncRNA DARS-AS1 Modulates TSPAN1-Mediated ITGA2 Hypomethylation by Interaction with miR-194-5p Thus Promoting Ovarian Cancer Progression.
    Li J; Gao H; Chen B; Li L; Wang Q; Gao Z
    Stem Cells Int; 2022; 2022():4041550. PubMed ID: 36187230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA OIP5-AS1 Promotes the Proliferation of Hemangioma Vascular Endothelial Cells via Regulating miR-195-5p/NOB1 Axis.
    Zhang J; Zhao T; Tian L; Li Y
    Front Pharmacol; 2019; 10():449. PubMed ID: 31068824
    [No Abstract]   [Full Text] [Related]  

  • 38. LncRNA MIF-AS1 aggravates the progression of ovarian cancer by sponging miRNA-31-5p.
    Fan Y; Wang L; Han XC; Ma HY; Zhang N; Zhe L
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2248-2255. PubMed ID: 32196575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C; Zhai J; Fu Y
    Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p.
    Wang D; Wang Z; Zhang L; Sun S
    Transl Oncol; 2021 Jan; 14(1):100958. PubMed ID: 33248413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.